Immunoblot analysis of cell cycle proteins showed that, following 24/48 h treatment with BSHE (GR50), p21, a CDK inhibitor transcriptionally controlled by p53 that can induce G1 arrest, increased in all cell lines except for PC3 prostate cancer cells. This evidence concerns the gene TP53 and prostate cancer.